Mrs. Delese Mimi Darko graduated as a Bachelor of Pharmacy from the KNUST and her postgraduate Masters degree in Business Administration was from the University of Northampton. She has risen through the ranks of the Food and Drugs Authority (FDA) to become the first female Chief Executive Officer. The FDA process of designation by the NEPAD/African Medicines Regulatory Harmonization (AMRH) as a Regional Centers of Regulatory Excellence was led by her in 3 very critical areas, namely, Medicines Safety (pharmacovigilance), Clinical Trials and Drug Registration. She serves on several international and local advisory committees and bodies including the CIOMS Vaccine Safety Working Group, The WHO Scientific Advisory Group for the Blueprint on Research and Development Preparedness, CEPI SAC, Brighton Collaboration SB. She has received several awards for her exemplary and commendable work. Notable amongst them are the United Nations (UN) Inter-Agency Task Force (UNIATF) award on the Prevention and Control of Non-Communicable Diseases in New York and the GLiTZ Africa’s award for Ghana Women of the Year Honours 2019 (Excellence in Health). She is the Chairperson of the African Vaccines Regulatory Forum (AVAREF).